Andreas Macura

Andreas Macura has a diverse work experience in the healthcare and pharmaceutical industry. Andreas began their career at Fresenius Kabi as a Quality Controller in 2009 before transitioning to Scandinavian Outcomes AB, where they worked as a Clinical Research Associate from 2009 to 2011. Following this, Andreas joined Takeda as a Medical Information Manager and Drug Safety Officer from 2011 to 2015.

In 2015, Andreas joined Chiltern as a CRA2, responsible for clinical research activities. Andreas was later promoted to the position of Senior CRA in 2018 before leaving the company in 2018. Subsequently, Andreas joined Medpace in 2019 as a Senior Clinical Research Associate and later took on the role of CRA Manager from 2019 to 2020.

Currently, Andreas is serving as the Chief Product Officer at AlgoDx - Algorithm Diagnostics, a position that they assumed in May 2021. Prior to this role, they also worked as a Clinical Project Manager at AlgoDx from 2020 to 2022.

Overall, Andreas has worked in various roles within the clinical research field and has gained valuable experience in project management, drug safety, and quality control.

Andreas Macura attended Uppsala University from 2002 to 2009, where they earned a Master of Science degree in Pharmacy. In 2004 and 2005, they also studied at the National University of Singapore, focusing on Pharmacy and Japanese. From 2006 to 2007, Andreas attended Sophia University, specializing in Japanese and Art. Additionally, in 2008, they briefly attended Keio University, with a specific interest in Pharmacokinetics.